Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
Coordonnateur : Kesharwani Prashant
Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
1. Introduction: An Overview of the anatomy and physiology of the lung2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer4. Polymeric nanoparticles based drug delivery for lung cancer5. Solid lipid nanoparticles based drug delivery for lung cancer6. Liposomes and niosomes based drug delivery for lung cancer7. Dendrimers based drug delivery for lung cancer8. Micelles based drug delivery for lung cancer9. Nanoemulsions based drug delivery for lung cancer10. Nanomedicine-based inhalation treatments for lung cancer11. Towards development of novel diagnostic nano-imaging platform for lung cancer12. Hydrogel based drug delivery for lung cancer13. Quantum dots based drug delivery for lung cancer
Dr. Prashant Kesharwani is working as an assistant professor of pharmaceutics at the School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 20 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also a receipt of several internationally acclaimed awards such as the most prestigious “Ramanujan Fellowship Award from the Science and Engineering Research Board, Government of India. He actively participates in outreach and scientific dissemination for the service of the wider community.
- Provides an overview of an array of nanotechnology-based drug delivery systems
- Examines the design, synthesis and application of different nanocarriers in drug and gene delivery
- Provides an in-depth understanding of the design of targeted nanotherapeutics and technologies and its implication in various site-specific cancers
Date de parution : 01-2019
Ouvrage de 340 p.
19x23.3 cm
Thèmes de Nanotechnology-Based Targeted Drug Delivery Systems for... :
Mots-clés :
Biocompatibility; Breathing; Cancer therapies; Cancer; Carbon dots; Chemotherapy; Codelivery; Conventional imaging tools; Dendrimer; Diagnosis at early stages; Drug delivery; Drug resistance; Dry powder inhaler; Expiration; Gene delivery; Gene therapy; Hydrogel; Inhaled nanomedicine; Liposomes; Local delivery; Lung cancer; Lung imaging; Lung; Lungs; Lymphatic transport; Magnetic nanoparticles; Metallic nanoparticles; Metastasis; Molecular diagnosis; Molecular pathways; Nanocarriers; Nanoemulsion; Nano-imaging probes; Nebulizer; Nonsmall-cell lung cancer (NSCLC)Overexpression; Nonsmall-cell lung cancer; Nonviral vectors; NSCLC; PAMAM; Passive targeting; PLL; Pluronic; Poly(amino-acid)Polyester; Polymer; Polymeric micelle; PPI; Pulmonary delivery; Pulmonary drug delivery; Quantum dots; Receptors; Respiratory system; Safety; Small-cell lung cancer (SCLC)Small-cell lung cancer; Solid lipid nanoparticles; Targeted therapy; Theranostic; TPGS; Trachea
